{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T10:49:34Z","timestamp":1782989374110,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,2]]},"DOI":"10.7759\/cureus.111938","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T09:52:36Z","timestamp":1782985956000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparative Epidemiological and Metabolic Profiling in Alcoholic Versus Metabolic Dysfunction-Associated Steatotic Liver Disease: A Western India Cross-Sectional Analysis"],"prefix":"10.7759","author":[{"given":"Sushant S","family":"Dhanavade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandakini S","family":"Kshirsagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axita C","family":"Vani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella ME","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al.. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023, 78:1966-1986. 10.1097\/HEP.0000000000000520","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi ZM","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L, et al.. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019, 71:793-801. 10.1016\/j.jhep.2019.06.021","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015","volume":"3","author":"Akinyemiju T","year":"2017","unstructured":"Akinyemiju T, Abera S, Ahmed M, et al.. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015. JAMA Oncol. 2017, 3:1683-1691. 10.1001\/jamaoncol.2017.3055","journal-title":"JAMA Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.469","article-title":"ACG Clinical Guideline: alcoholic liver disease","volume":"113","author":"Singal AK","year":"2018","unstructured":"Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. ACG Clinical Guideline: alcoholic liver disease. Am J Gastroenterol. 2018, 113:175-194. 10.1038\/ajg.2017.469","journal-title":"Am J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2015.02.006","article-title":"Non-alcoholic fatty liver disease and metabolic syndrome-position paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology","volume":"5","author":"Duseja A","year":"2015","unstructured":"Duseja A, Singh SP, Saraswat VA, et al.. Non-alcoholic fatty liver disease and metabolic syndrome-position paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. J Clin Exp Hepatol. 2015, 5:51-68. 10.1016\/j.jceh.2015.02.006","journal-title":"J Clin Exp Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47687-3","article-title":"Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis","volume":"9","author":"Liu Y","year":"2019","unstructured":"Liu Y, Zhong GC, Tan HY, Hao FB, Hu JJ. Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis. Sci Rep. 2019, 9:11124. 10.1038\/s41598-019-47687-3","journal-title":"Sci Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter TG","year":"2020","unstructured":"Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020, 158:1851-1864. 10.1053\/j.gastro.2020.01.052","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases","volume":"71","author":"Crabb DW","year":"2020","unstructured":"Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol-associated liver diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology. 2020, 71:306-333. 10.1002\/hep.30866","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2023.10.002","article-title":"Etiological spectrum of cirrhosis in India: a systematic review and meta-analysis","volume":"14","author":"Swaroop S","year":"2024","unstructured":"Swaroop S, Vaishnav M, Arora U, et al.. Etiological spectrum of cirrhosis in India: a systematic review and meta-analysis. J Clin Exp Hepatol. 2024, 14:101291. 10.1016\/j.jceh.2023.10.002","journal-title":"J Clin Exp Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.113758","article-title":"Clinicopathological characteristics and metabolic profile of non-alcoholic fatty liver disease in Indian patients with normal body mass index: do they differ from obese or overweight non-alcoholic fatty liver disease?","volume":"17","author":"Kumar R","year":"2013","unstructured":"Kumar R, Rastogi A, Sharma MK, Bhatia V, Garg H, Bihari C, Sarin SK. Clinicopathological characteristics and metabolic profile of non-alcoholic fatty liver disease in Indian patients with normal body mass index: do they differ from obese or overweight non-alcoholic fatty liver disease?. Indian J Endocrinol Metab. 2013, 17:665-671. 10.4103\/2230-8210.113758","journal-title":"Indian J Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam M","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, et al.. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020, 73:202-209. 10.1016\/j.jhep.2020.03.039","journal-title":"J Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis","volume":"54","author":"Hernaez R","year":"2011","unstructured":"Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, Clark JM. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011, 54:1082-1090. 10.1002\/hep.24452","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL Clinical Practice Guidelines: management of alcohol-related liver disease","volume":"69","year":"2018","unstructured":"EASL Clinical Practice Guidelines. management of alcohol-related liver disease. J Hepatol. 2018, 69:154-181. 10.1016\/j.jhep.2018.03.018","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-S002","article-title":"2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022","volume":"45","year":"2022","unstructured":"2. Classification and Diagnosis of Diabetes. Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022, 45:S17-S38. 10.2337\/dc22-S002","journal-title":"Diabetes Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension Global Hypertension Practice Guidelines","volume":"75","author":"Unger T","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, et al.. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020, 75:1334-1357. 10.1161\/HYPERTENSIONAHA.120.15026","journal-title":"Hypertension"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"WHO Expert Consultation","year":"2004","unstructured":"WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004, 363:157-163. 10.1016\/S0140-6736(03)15268-3","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-0357-5_3","article-title":"Timeline Follow-Back","author":"Sobell LC","year":"1992","unstructured":"Sobell LC, Sobell MB. Timeline Follow-Back. Measuring alcohol consumption. Litten RZ, Allen JP (ed): Humana Press, Totowa, NJ; 1992. 41-72. 10.1007\/978-1-4612-0357-5_3"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1902","article-title":"Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis","volume":"41","author":"Mantovani A","year":"2018","unstructured":"Mantovani A, Byrne CD, Bonora E, Targher G. Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis. Diabetes Care. 2018, 41:372-382. 10.2337\/dc17-1902","journal-title":"Diabetes Care"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/add.13757","article-title":"The relationship between different dimensions of alcohol use and the burden of disease-an update","volume":"112","author":"Rehm J","year":"2017","unstructured":"Rehm J, Gmel GE Sr, Gmel G, et al.. The relationship between different dimensions of alcohol use and the burden of disease-an update. Addiction. 2017, 112:968-1001. 10.1111\/add.13757","journal-title":"Addiction"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30226","article-title":"Effect of alcohol consumption on survival in nonalcoholic fatty liver disease: a national prospective cohort study","volume":"70","author":"Hajifathalian K","year":"2019","unstructured":"Hajifathalian K, Torabi Sagvand B, McCullough AJ. Effect of alcohol consumption on survival in nonalcoholic fatty liver disease: a national prospective cohort study. Hepatology. 2019, 70:511-521. 10.1002\/hep.30226","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1080\/00365513.2019.1700428","article-title":"Metabolic syndrome but not genetic polymorphisms known to induce NAFLD predicts increased total mortality in subjects with NAFLD (OPERA study)","volume":"80","author":"Karajam\u00e4ki AJ","year":"2020","unstructured":"Karajam\u00e4ki AJ, Hukkanen J, Kauma H, Kes\u00e4niemi YA, Ukkola O. Metabolic syndrome but not genetic polymorphisms known to induce NAFLD predicts increased total mortality in subjects with NAFLD (OPERA study). Scand J Clin Lab Invest. 2020, 80:106-113. 10.1080\/00365513.2019.1700428","journal-title":"Scand J Clin Lab Invest"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi A","year":"2018","unstructured":"Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, Knight R. The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol. 2018, 15:397-411. 10.1038\/s41575-018-0011-z","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.hep.2022.11.010","article-title":"A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes","volume":"78","author":"Ajmera V","year":"2023","unstructured":"Ajmera V, Cepin S, Tesfai K, et al.. A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes. J Hepatol. 2023, 78:471-478. 10.1016\/j.hep.2022.11.010","journal-title":"J Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 Global NAFLD prevalence: a systematic review and meta-analysis","volume":"20","author":"Le MH","year":"2022","unstructured":"Le MH, Yeo YH, Li X, et al.. 2019 Global NAFLD prevalence: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2022, 20:2809-2817.e28. 10.1016\/j.cgh.2021.12.002","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29338","article-title":"Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: prediction and impact on long-term survival","volume":"66","author":"Altamirano J","year":"2017","unstructured":"Altamirano J, L\u00f3pez-Pelayo H, Michelena J, et al.. Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: prediction and impact on long-term survival. Hepatology. 2017, 66:1842-1853. 10.1002\/hep.29338","journal-title":"Hepatology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman SL","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018, 24:908-922. 10.1038\/s41591-018-0104-9","journal-title":"Nat Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz HK","year":"2018","unstructured":"Seitz HK, Bataller R, Cortez-Pinto H, et al.. Alcoholic liver disease. Nat Rev Dis Primers. 2018, 4:16. 10.1038\/s41572-018-0014-7","journal-title":"Nat Rev Dis Primers"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti E","year":"2016","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016, 65:1038-1048. 10.1016\/j.metabol.2015.12.012","journal-title":"Metabolism"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/499145-comparative-epidemiological-and-metabolic-profiling-in-alcoholic-versus-metabolic-dysfunction-associated-steatotic-liver-disease-a-western-india-cross-sectional-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T09:52:38Z","timestamp":1782985958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/499145-comparative-epidemiological-and-metabolic-profiling-in-alcoholic-versus-metabolic-dysfunction-associated-steatotic-liver-disease-a-western-india-cross-sectional-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.111938","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,2]]}}}